Trials / Recruiting
RecruitingNCT05982626
Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Huashan Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety, biodistribution, radiation dosimetry, and uptake in tumor lesions of patients with Her2-positive metastatic breast cancer after injection of \[131I\]/\[68Ga\]SGMIB-ZT-199.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | 68Ga/131I-SGMIB-ZT-199 | 68Ga-SGMIB-ZT-199: PET imaging; 131I-SGMIB-ZT-199: SPECT imaging. |
Timeline
- Start date
- 2023-05-15
- Primary completion
- 2024-12-31
- Completion
- 2025-03-31
- First posted
- 2023-08-08
- Last updated
- 2024-04-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05982626. Inclusion in this directory is not an endorsement.